// App-Quantinova.ai

: Promoting anti-tumor immunity via bispecific T cell engaging cytokine (biteokine) therapy (P1312)

Researchers

Presenter

  • Priscilla Do

Principal Investigators

  • Lacey A. Perdue

  • Andy Chyong

  • Curtis J. Henry

  • Christopher C. Porter

  • Erik C. Dreaden

Medical Centers

  • Coulter Department of Biomedical Engineering,

  • Georgia Inst of Technology and Emory Univ Sch of Med, Atlanta, GA

  • Aflac Cancer and Blood Disorders Center, Atlanta, GA

  • Department of pediatrics,

  • Childrens Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA, United States

  • Winship Cancer Institute,

  • Parker H. Petit Institute of Bioengineering and Bioscience

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Interleukin 12

Drug/Treatment

  • Blinatumomab

  • IL-12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved